Word

CELLARIX

Status

Pending

Status Code

686

Status Date

Tuesday, April 2, 2024

Serial Number

97792411

Mark Type

4000

Filing Date

Monday, February 13, 2023

Published for Opposition

Tuesday, April 2, 2024

Trademark Owner History

Cellarity, Inc. - Owner At Publication

Classifications

5 Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

42 Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; scientific research in the field of drug discovery and development; biomedical research services; bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development

Trademark Events

Apr 2, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 2, 2024

Published For Opposition

Mar 13, 2024

Notification Of Notice Of Publication E-Mailed

Feb 22, 2024

Approved For Pub - Principal Register

Feb 21, 2024

Examiner's Amendment Entered

Feb 21, 2024

Assigned To Lie

Feb 21, 2024

Notification Of Examiners Amendment E-Mailed

Feb 21, 2024

Examiners Amendment E-Mailed

Feb 21, 2024

Examiners Amendment -Written

Oct 27, 2023

Application Extension Granted/Receipt Provided

Oct 27, 2023

Application Extension To Response Period - Received

Jul 28, 2023

Notification Of Non-Final Action E-Mailed

Jul 28, 2023

Non-Final Action E-Mailed

Jul 28, 2023

Non-Final Action Written

Jul 21, 2023

Assigned To Examiner

Mar 2, 2023

New Application Office Supplied Data Entered

Feb 16, 2023

New Application Entered